This is not the most recent version of the article. View current version (21 JAN 2014)

Diagnostic Test Accuracy Review

You have full text access to this OnlineOpen article

Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults

  1. Karen R Steingart1,*,
  2. Hojoon Sohn2,
  3. Ian Schiller3,
  4. Lorie A Kloda4,
  5. Catharina C Boehme5,
  6. Madhukar Pai2,
  7. Nandini Dendukuri2

Editorial Group: Cochrane Infectious Diseases Group

Published Online: 31 JAN 2013

Assessed as up-to-date: 7 SEP 2012

DOI: 10.1002/14651858.CD009593.pub2


How to Cite

Steingart KR, Sohn H, Schiller I, Kloda LA, Boehme CC, Pai M, Dendukuri N. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database of Systematic Reviews 2013, Issue 1. Art. No.: CD009593. DOI: 10.1002/14651858.CD009593.pub2.

Author Information

  1. 1

    University of Washington, School of Public Health, Department of Health Services, Seattle, Washington, USA

  2. 2

    McGill University, Department of Epidemiology, Biostatistics and Occupational Health, Montreal, Quebec, Canada

  3. 3

    McGill University Health Centre, Department of Clinical Epidemiology, Montreal, Canada

  4. 4

    McGill University, Library, Montreal, Quebec, Canada

  5. 5

    Foundation for Innovative New Diagnostics (FIND), Geneva, Switzerland

*Karen R Steingart, Department of Health Services, University of Washington, School of Public Health, Seattle, Washington, 98195-7230, USA. karenst@uw.edu.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 31 JAN 2013

SEARCH

This is not the most recent version of the article. View current version (21 JAN 2014)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Niaz Banaei, Stanley C. Deresinski, Benjamin A. Pinsky, Murray and Nadel's Textbook of Respiratory Medicine, 2016,

    CrossRef

  2. 2
    Susana Barreda-García, María José González-Álvarez, Noemí de-los-Santos-Álvarez, Juan José Palacios-Gutiérrez, Arturo J. Miranda-Ordieres, María Jesús Lobo-Castañón, Attomolar quantitation of Mycobacterium tuberculosis by asymmetric helicase-dependent isothermal DNA-amplification and electrochemical detection, Biosensors and Bioelectronics, 2015, 68, 122

    CrossRef

  3. 3
    Kanokwan Pinyopornpanish, Romanee Chaiwarith, Chansom Pantip, Rassamee Keawvichit, Kanlaya Wongworapat, Phadungkiat Khamnoi, Khuanchai Supparatpinyo, Thira Sirisanthana, Comparison of Xpert MTB/RIF Assay and the Conventional Sputum Microscopy in DetectingMycobacterium tuberculosisin Northern Thailand, Tuberculosis Research and Treatment, 2015, 2015, 1

    CrossRef

  4. 4
    Allison S. Rhines, Midori Kato-Maeda, Marcus W. Feldman, Model of the Effects of Improving TB Diagnosis on Infection Dynamics in Differing Demographic and HIV-Prevalence Scenarios, Journal of Tuberculosis Research, 2015, 03, 01, 1

    CrossRef

  5. 5
    Poojan Shrestha, Amit Arjyal, Maxine Caws, Krishna Govinda Prajapati, Abhilasha Karkey, Sabina Dongol, Saruna Pathak, Shanti Prajapati, Buddha Basnyat, The Application of GeneXpert MTB/RIF for Smear-Negative TB Diagnosis as a Fee-Paying Service at a South Asian General Hospital, Tuberculosis Research and Treatment, 2015, 2015, 1

    CrossRef

  6. 6
    Ivor Langley, Hsien-Ho Lin, Saidi Egwaga, Basra Doulla, Chu-Chang Ku, Megan Murray, Ted Cohen, S Bertel Squire, Assessment of the patient, health system, and population effects of Xpert MTB/RIF and alternative diagnostics for tuberculosis in Tanzania: an integrated modelling approach, The Lancet Global Health, 2014, 2, 10, e581

    CrossRef

  7. 7
    Anca Lelia Riza, Fiona Pearson, Cesar Ugarte-Gil, Bachti Alisjahbana, Steven van de Vijver, Nicolae M Panduru, Philip C Hill, Rovina Ruslami, David Moore, Rob Aarnoutse, Julia A Critchley, Reinout van Crevel, Clinical management of concurrent diabetes and tuberculosis and the implications for patient services, The Lancet Diabetes & Endocrinology, 2014, 2, 9, 740

    CrossRef

  8. 8
    Paul K Drain, Emily P Hyle, Farzad Noubary, Kenneth A Freedberg, Douglas Wilson, William R Bishai, William Rodriguez, Ingrid V Bassett, Diagnostic point-of-care tests in resource-limited settings, The Lancet Infectious Diseases, 2014, 14, 3, 239

    CrossRef

  9. 9
    Grant Theron, Jonny Peter, David Dowdy, Ivor Langley, S Bertel Squire, Keertan Dheda, Do high rates of empirical treatment undermine the potential effect of new diagnostic tests for tuberculosis in high-burden settings?, The Lancet Infectious Diseases, 2014, 14, 6, 527

    CrossRef

  10. 10
    Grant Theron, Lynn Zijenah, Duncan Chanda, Petra Clowes, Andrea Rachow, Maia Lesosky, Wilbert Bara, Stanley Mungofa, Madhukar Pai, Michael Hoelscher, David Dowdy, Alex Pym, Peter Mwaba, Peter Mason, Jonny Peter, Keertan Dheda, Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial, The Lancet, 2014, 383, 9915, 424

    CrossRef

  11. 11
    D. Hillemann, E. Richter, S. Andres, S. Rüsch-Gerdes, Fortschritte in der bakteriologischen und molekularen Diagnostik der Tuberkulose, Der Pneumologe, 2014, 11, 1, 28

    CrossRef

  12. 12
    Christian Wejse, Point-of-care diagnostics for tuberculosis elimination?, The Lancet, 2014, 383, 9915, 388

    CrossRef

  13. 13
    Aubri S. Carman, Arpita G. Patel, Science with Societal Implications: Detecting Mycobacterium tuberculosis in Africa, Clinical Microbiology Newsletter, 2014, 36, 10, 73

    CrossRef

  14. 14
    Pan Xin, Zeng Siliang, Cai Jialin, Zhang Bin, Pan Boju, Pan Zhonglei, Wu Ying, Wang Ying, Zhou Yi, Fang Wei, Chen Min, Liao Wanqing, Yu XiuZhen, Tao Min, Zhang Jun, Song Wei, Screening novel diagnostic marker of Mycobacterium tuberculosis, African Journal of Microbiology Research, 2014, 8, 8, 776

    CrossRef

  15. 15
    Jorge Enrique Gómez Marín, Sobre la necesidad de modernizar la vigilancia epidemiológica y de ampliar el uso del diagnóstico molecular para las enfermedades infecciosas en Colombia, Infectio, 2014, 18, 3, 77

    CrossRef

  16. 16
    Ana Méndez Echevarría, Tuberculosis, Anales de Pediatría Continuada, 2014, 12, 3, 124

    CrossRef

  17. 17
    Yuria Ablanedo-Terrazas, Claudia Alvarado-de la Barrera, Ramón Hernández-Juan, Matilde Ruiz-Cruz, Gustavo Reyes-Terán, Xpert MTB/RIF for diagnosis of tuberculous cervical lymphadenitis in HIV-infected patients, The Laryngoscope, 2014, 124, 6
  18. 18
    William A Wells, Catharina C Boehme, Frank GJ Cobelens, Colleen Daniels, David Dowdy, Elizabeth Gardiner, Jan Gheuens, Peter Kim, Michael E Kimerling, Barry Kreiswirth, Christian Lienhardt, Khisi Mdluli, Madhukar Pai, Mark D Perkins, Trevor Peter, Matteo Zignol, Alimuddin Zumla, Marco Schito, Alignment of new tuberculosis drug regimens and drug susceptibility testing: a framework for action, The Lancet Infectious Diseases, 2013, 13, 5, 449

    CrossRef

  19. 19
    Jerome H. Chin, Farrah J. Mateen, Central Nervous System Tuberculosis: Challenges and Advances in Diagnosis and Treatment, Current Infectious Disease Reports, 2013, 15, 6, 631

    CrossRef

  20. 20
    Simon Walusimbi, Freddie Bwanga, Ayesha De Costa, Melles Haile, Sven Hoffner, Moses Joloba, Evaluation of the Xpert® MTB/Rif test, microscopic observation drug susceptibility test and nitrate reductase assay, for rapid and accurate diagnosis of smear-negative tuberculosis in HIV patients, International Journal of Mycobacteriology, 2013, 2, 3, 148

    CrossRef

  21. 21
    Ljiljana Zmak, Mateja Jankovic, Vera Katalinic Jankovic, Evaluation of Xpert MTB/RIF assay for rapid molecular diagnosis of tuberculosis in a two-year period in Croatia, International Journal of Mycobacteriology, 2013, 2, 3, 179

    CrossRef

  22. 22
    Madhukar Pai, Ziad A. Memish, New tuberculosis tools are here: Can we deliver them for maximal impact?, Journal of Epidemiology and Global Health, 2013, 3, 1, 1

    CrossRef

  23. 23
    Heather J Zar, Lesley Workman, Washiefa Isaacs, Keertan Dheda, Widaad Zemanay, Mark P Nicol, Rapid diagnosis of pulmonary tuberculosis in African children in a primary care setting by use of Xpert MTB/RIF on respiratory specimens: a prospective study, The Lancet Global Health, 2013, 1, 2, e97

    CrossRef

  24. 24
    Jerard M. Selvam, The accuracy of the Xpert®MTB/RIF assay compared to smear microscopy and culture for detecting pulmonary tuberculosis and rifampicin resistance in adults, Clinical Epidemiology and Global Health, 2013, 1, 2, 85

    CrossRef

  25. 25
    Danielle Cohen, Elizabeth Corbett, David Tovey, Cochrane Database of Systematic Reviews, 2013,

    CrossRef

  26. You have free access to this content26
    Karen R Steingart, Ian Schiller, David J Horne, Madhukar Pai, Catharina C Boehme, Nandini Dendukuri, Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults, The Cochrane Library,